I would suggest Frylabs for babesia, proto. I think they are one of the most comprehensive. Insurance does kick in for some testing. Forgot to add link/info:
frylabs.com/services-list/vector-borne-and-infectious-diseases/"Fry Laboratories, L.L.C. is a Clinical Research and Development Laboratory located in Scottsdale, Arizona. We are dedicated to the study and diagnosis of bacterial and eukaryotic vector-borne and infectious diseases. We are particularly interested in the studying underlying etiologic triggers for a wide variety of inflammatory and chronic disorders including: Chronic Fatigue Syndrome, Gulf War Veterans Illness, Fibromyalgia, “Chronic Lyme”, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Parkinson’s Disease, and vascular disease.
Our laboratory provides clinical diagnostics for the common North American vector-borne, infectious, and protozoal diseases using a variety of FDA-approved and commercial assays. These approaches include serologic and microscopic detection assays. In addition to these standard protocols, we offer cutting-edge technologies created through our research and development efforts as Laboratory Developed Tests (LDTs). In this category of testing, we offer molecular DNA based tests along with special and advanced staining protocols. By offering this unique combination of standard commercial assays and newly developed techniques, we feel that we offer great assistance to the clinician in the formation of a treatment strategy and plan for many chronic illnesses. Fry Laboratories, L.L.C. is CLIA approved and participates in the College of American Pathology (CAP) and American Proficiency Institute (API) quality assurance programs.
Technology Driven
Recent technological advances are primarily responsible for a vast expansion of the types of diagnostic tests that are now available. Fry Laboratories, L.L.C. has invested significant resources, research, and development in translating some of the recent technologies to the sphere of vector-borne and infection identification.
Modern medicine has focused primarily on reductive identification technologies where tests are designed to identify a specific organism or a restricted set of organisms. Recently, Next Generation Sequencing (NGS), advanced microscopy, and molecular diagnostics have widened the detection envelope. Broad-spectrum microscopy methods may rapidly detect the presence of organisms, while deep sequence analysis can reveal the identity of the organism.
Microscopy, serology, and molecular diagnostics stand as the three main pillars of identification technologies for complex and / or fastidious organism identification. We are committed to expanding the testing options available to the infectious disease expert, the general healthcare professional, and to hospital laboratories.
Next Generation DNA Sequencing and Pathogen Identification
Breakthroughs in DNA sequencing technology have enabled a new field of Pan-Bacterial identification, whereby entire populations of DNA are sequenced and identified rather than individual organisms one at a time. Fry Laboratories, L.L.C. has harnessed Next Generation DNA Sequencing to allow for a more accurate picture of the microbial contributions to a population in addition to the identification of organisms based on DNA sequence alone. Standard medical microbiology methods utilize culture-based technologies; however, it is becoming increasingly clear that the majority of bacteria are fastidious and these uncultivable bacteria are medically important.
By skipping culture methods and biochemical assays a more rapid result may be obtained; not just for those few bacteria that are cultivable, but for the entire uncultivable population as a whole. This type of technology is estimated to save the average hospital over 17 million dollars a year in improved drug selection, shorter hospitalizations, and better patient outcomes. This technology fills an immediate need for identification of “sterile” or “uncultivable” infections where empiric therapy is utilized. Fry Laboratories, L.L.C. is currently offering DNA sequencing for both prokaryotic (bacteria and archaea) and eukaryotic (fungi and protozoa) testing for a wide range of domestic and international physicians (virus testing is in development)."
Post Edited (happyjo) : 4/18/2016 7:36:05 AM (GMT-6)